Why MedAssets Shares Tumbled Then Recovered

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of health-care information technology provider MedAssets (NASDAQ: MDAS  ) fell as much as 11% following its fourth-quarter earnings report, but have since reversed course to a gain of 4% as of this writing.

So what: For the quarter, MedAssets reported a 4.5% rise in sales to $163.8 million and earnings per share of $0.27, which was nearly 16% below the year-ago period. Although revenue was higher than expected, investors honed in on MedAssets' $0.01 EPS miss relative to the Street's expectations and drove the stock down early. Looking ahead, MedAssets anticipates 2013 revenue of $670 million to $684 million with EPS of $1.22-$1.32, which compares favorably with the $676.3 million and $1.29 in EPS consensus.

Now what: It appears that the biggest reason MedAssets reversed course has more to do with it renewing its contract with the Resource Group, which it counts as a major customer, than its actual guidance. However, from the midpoint of its 2013 guidance, MedAssets seems very fairly valued at 15 times this year's earnings. As health organizations become more complex, I wouldn't be surprised if they continued to turn to the type of software provided by MedAssets, but I would also be careful not to chase a company like this too high.

Craving more input? Start by adding MedAssets to your free and personalized watchlist so you can keep up on the latest news with the company.

While you can certainly make huge gains in health-care IT companies like MedAssets, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2269464, ~/Articles/ArticleHandler.aspx, 4/16/2014 4:03:06 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement